Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy BoB 150 Call, Dr Reddy's 3050 Call: VK Sharma

      VK Sharma of HDFC Securities recommends buying Bank of Baroda 150 Call and Dr Reddy's Labs 3050 Call.

    • Like Sun Pharma, Cipla, Glenmark Pharma: Deven Choksey

      Deven Choksey of KRChoksey Invst Managers likes Sun Pharmaceutical Industries, Cipla and Glenmark Pharma from the pharma space.

    • Buy Shriram Transport; sell SBI, Titan, Wipro: Prakash Gaba

      Prakash Gaba of prakashgaba.com recommends buying Shriram Transport Finance and advises selling SBI, Titan Company and Wipro.

    • Positive on Dr Reddy's Labs, says Mayuresh Joshi

      Mayuresh Joshi of Angel Broking has a positive view on Dr Reddy's Labs with a long term view.

    • Go long in Dr Reddy's Laboratories: Siddarth Bhamre

      Siddarth Bhamre of Angel Broking recommends going long in Dr Reddy's Laboratories for a target of Rs 3342.

    • Sell HDFC, Dr Reddy's; SBI may test Rs 192, buy IFCI: Rajat Bose

      Rajat K Bose of rajatkbose.com recommends selling HDFC and Dr Reddy's Labs and advises buying IFCI and feels that SBI may test Rs 192.

    • Like Alembic Pharma, buy on dips: Mehraboon Irani

      Mehraboon Irani of Nirmal Bang Securities likes Alembic Pharma and recommends buying the stock on dips.

    • Buy Lupin on declines, says Ambareesh Baliga

      Ambareesh Baliga, Market Expert is of the view that one can buy Lupin on declines.

    • Buy Dr Reddy's Labs, Reliance Industries; sell Colgate: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Dr Reddy's Labs and Reliance Industries and advises selling Colgate Palmolive.

    • Super Six stocks you can bet on March 8

      Rakesh Bansal of RK Global is of the view that one may buy Apollo Tyres with a target of Rs 180.

    • Buy SBI, BHEL, Bank of Baroda: Rajat Bose

      Rajat Bose of rajatkbose.com suggests buying Buy SBI, BHEL and Bank of Baroda.

    • Bull's Eye: Buy UPL, NELCO, IGL, Jet; sell SKS Micro

      Shahina Mukadam, Independent Market Expert advises buying Aurobindo Pharma with a target of Rs 750.

    • Buy Jubilant Life, Dr Reddy's Lab, L&T: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Larsen and Toubro, Aban Offshore and Dr Reddy's Laboratories.

    • Buy Biocon, UltraTech Cement: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon and UltraTech Cement.

    • Budget 2016 India: Buy Biocon; sell Page Ind, Dr Reddy's, Vedanta, Havells: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Biocon and advises selling Page Industries, Dr Reddy's Labs, Vedanta and Havells India.

    • Buy Lupin, Dr Reddy's Labs: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Lupin and DR Reddy's Labs.

    • Buy Castrol; HCL Tech may hit Rs 795, Dr Reddy's Rs 2900: Gaba

      Prakash Gaba of prakashgaba.com recommends buying Castrol India and feels that HCL Tech may hit Rs 795 while Dr Reddy's Labs may test Rs 2900.

    • Buy Cadila Healthcare; pharma may outperform Nifty: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Cadila Healthcare and feels that pharma may outperform Nifty.

    • See upside in Sun Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may see upside in Sun Pharma.

    • Buy Amara Raja Batteries, sell Jubilant Foodworks: Sukhani

      According to Sudarshan Sukhani of s2analytics.com, one may buy Amara Raja Batteries and Dr Reddy's Laboratories.

    • Bull's Eye: Buy Pidilite, Bata, Jet, SRF, Dr Reddy's, Rel Cap

      Vishal Malkan of malkansview.com advises buying Pidilite Industries with a target of Rs 630.

    • Buy Dr Reddy's Labs on dips for long term: Mayuresh Joshi

      Mayuresh Joshi of Angel Broking is of the view that one can buy Dr Reddy's Laboratories on dips for long term.

    • Dr Reddy's may head lower, buy HDFC on dips: Ambareesh Baliga

      Ambareesh Baliga, Market Expert is of the view that Dr Reddy's Labs may head lower and feels that one can buy HDFC on dips.

    • Sell Tata Steel, Hindalco; Divis Lab may head lower: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling Tata Steel and Hindalco and feels that Aurobindo Pharma and Divis Lab may head lower.

    • Short Dr Reddy's, LIC Housing Finance, Coal India: Prakash Gaba

      Prakash Gaba of prakashgaba.com recommends shorting Dr Reddy's Laboratories, LIC Housing Finance and Coal India.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347